These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29954724)

  • 1. Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset.
    Peddie D; Small SS; Badke K; Bailey C; Balka E; Hohl CM
    JMIR Med Inform; 2018 Jun; 6(2):e10248. PubMed ID: 29954724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design.
    Peddie D; Small SS; Badke K; Wickham ME; Bailey C; Chruscicki A; Ackerley C; Balka E; Hohl CM
    JMIR Res Protoc; 2016 Aug; 5(3):e169. PubMed ID: 27538362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug event reporting systems: a systematic review.
    Bailey C; Peddie D; Wickham ME; Badke K; Small SS; Doyle-Waters MM; Balka E; Hohl CM
    Br J Clin Pharmacol; 2016 Jul; 82(1):17-29. PubMed ID: 27016266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record.
    Chruscicki A; Badke K; Peddie D; Small S; Balka E; Hohl CM
    Springerplus; 2016; 5(1):1764. PubMed ID: 27795906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Clinicians Don't Report Adverse Drug Events: Qualitative Study.
    Hohl CM; Small SS; Peddie D; Badke K; Bailey C; Balka E
    JMIR Public Health Surveill; 2018 Feb; 4(1):e21. PubMed ID: 29487041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction of Information Related to Drug Safety Surveillance From Electronic Health Record Notes: Joint Modeling of Entities and Relations Using Knowledge-Aware Neural Attentive Models.
    Dandala B; Joopudi V; Tsou CH; Liang JJ; Suryanarayanan P
    JMIR Med Inform; 2020 Jul; 8(7):e18417. PubMed ID: 32459650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From adverse drug event detection to prevention. A novel clinical decision support framework for medication safety.
    Koutkias VG; McNair P; Kilintzis V; Skovhus Andersen K; Niès J; Sarfati JC; Ammenwerth E; Chazard E; Jensen S; Beuscart R; Maglaveras N
    Methods Inf Med; 2014; 53(6):482-92. PubMed ID: 25377477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting.
    Linder JA; Haas JS; Iyer A; Labuzetta MA; Ibara M; Celeste M; Getty G; Bates DW
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1211-5. PubMed ID: 21155192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An external facilitation intervention to increase uptake of an adverse drug event reporting intervention.
    Lau EY; Small SS; Butcher K; Cragg A; Loh GW; Shalansky S; Hohl CM
    Front Health Serv; 2023; 3():1106586. PubMed ID: 37332530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals.
    Stergiopoulos S; Brown CA; Felix T; Grampp G; Getz KA
    Drug Saf; 2016 Nov; 39(11):1117-1127. PubMed ID: 27638657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.
    Winnenburg R; Sorbello A; Ripple A; Harpaz R; Tonning J; Szarfman A; Francis H; Bodenreider O
    J Biomed Inform; 2015 Oct; 57():425-35. PubMed ID: 26342964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making Sense of Pharmacovigilance and Drug Adverse Event Reporting: Comparative Similarity Association Analysis Using AI Machine Learning Algorithms in Dogs and Cats.
    Xu X; Mazloom R; Goligerdian A; Staley J; Amini M; Wyckoff GJ; Riviere J; Jaberi-Douraki M
    Top Companion Anim Med; 2019 Dec; 37():100366. PubMed ID: 31837760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a computer-based adverse-drug-event monitor.
    Hwang SH; Lee S; Koo HK; Kim Y
    Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.
    Vilar S; Tatonetti NP; Hripcsak G
    Sci Rep; 2015 Mar; 5():8809. PubMed ID: 25744369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic web technologies.
    Jiang G; Wang L; Liu H; Solbrig HR; Chute CG
    Stud Health Technol Inform; 2013; 192():496-500. PubMed ID: 23920604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.